Peak Processing (ASX:PKP) 5-Day RSI: 43.80 (As of Jul. 13, 2026)


What is Peak Processing 5-Day RSI?

Peak Processing ASX:PKP 5-Day RSI is 43.80 as of Jul. 13, 2026. The stock has 7 warning signs investors should review. Among 1,044 Drug Manufacturers companies, Peak Processing ranks better than 69.25% on this metric.

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

As of today (2026-07-13), Peak Processing's 5-Day RSI is 43.80.

The industry rank for Peak Processing's 5-Day RSI or its related term are showing as below:

ASX:PKP's 5-Day RSI is ranked better than
69.25% of 1044 companies
in the Drug Manufacturers industry
Industry Median: 51.905 vs ASX:PKP: 43.80

Peak Processing  (ASX:PKP) 5-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections. A shorter period RSI is more reactive to recent price changes, so it can show early signs of reversals. 5-Day RSI is sometimes used together with 14-Day RSI in a two period divergence strategy.

Peak Processing 5-Day RSI Related Terms

ASX:PKP vs ZTS, UTHR: 5-Day RSI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Peak Processing's 5-Day RSI, along with its competitors' market caps and 5-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Peak Processing 5-Day RSI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Peak Processing's 5-Day RSI distribution charts can be found below:

* The bar in red indicates where Peak Processing's 5-Day RSI falls into.


Peak Processing  (ASX:PKP) 5-Day RSI Calculation

The formula for calculating RSI is:

RSI=100–[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 5-Day RSI →
What does a 5-Day RSI of 43.80 mean?
Peak Processing (ASX:PKP) has a 5-Day RSI of 43.80 as of Jul. 13, 2026. According to the industry distribution chart, Peak Processing ranks #321 out of 1044 companies in the Drug Manufacturers industry, placing it in the top 30.7%.
Is Peak Processing's 5-Day RSI too high?
Peak Processing's current 5-Day RSI is 43.80. The Drug Manufacturers industry median 5-Day RSI is 51.91. Peak Processing's value of 43.80 is 15.6% below this industry median. Based on the distribution chart, Peak Processing ranks #321 out of 1044 companies in the Drug Manufacturers industry, which is above the industry midpoint.
How does Peak Processing's 5-Day RSI compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Peak Processing ranks #321 out of 1044 companies for 5-Day RSI. This puts Peak Processing in the upper half of its industry. The industry median 5-Day RSI is 51.91. Peak Processing's value of 43.80 is 15.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Day RSI for a Drug Manufacturers company?
The median 5-Day RSI among Drug Manufacturers companies is 51.91, based on 1,044 companies in the industry. Companies in the top quartile (top 25%) have a 5-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 5-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Peak Processing's current 5-Day RSI of 43.80 is 15.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Day RSI mean?
A high 5-Day RSI can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median 5-Day RSI is 51.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Peak Processing's current 5-Day RSI is 43.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Peak Processing stock overvalued right now?
Based on GuruFocus' analysis, Peak Processing (ASX:PKP) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.02 — trading 70% above its estimated fair value. The current 5-Day RSI is 43.80 and 15.6% below the Drug Manufacturers industry median of 51.91. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Day RSI calculated?
5-Day RSI is calculated from a company's financial statements. For Peak Processing (ASX:PKP), the current 5-Day RSI is 43.80 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Peak Processing Business Description

Address 180 Lonsdale Street, Level 19, Melbourne, VIC, AUS, 3000
Peak Processing Ltd is engaged in the manufacturing, sales, and distribution of cannabis-based medicines and recreational cannabis products. The products of the company includes cannabis-infused beverage, Hydrocarbon Extracts, oils, vapes, topicals, powder, infused flowers, and others. The company is also engaged in manufacturing services for cannabis products and blending and mixing, bulk filling, packaging, labelling and lab testing work.